Company Filing History:
1 out of 5,081 
1 out of 4 
1 out of 38 
Years Active: 2017
Title: The Innovative Journey of Patrick Cormier in Cancer Treatment
Introduction
Patrick Cormier, an inventive mind hailing from Cléder, France, has made significant contributions to the field of cancer treatment. With a focus on novel peptides, his research aims to combat chronic lymphoid leukaemia, demonstrating his commitment to addressing critical health challenges.
Latest Patents
Cormier holds a valuable patent concerning peptides utilized for treating cancers, particularly chronic lymphoid leukaemia. The invention centers around the A1 peptide, defined by the sequence RRKYGRDFLLRF, alongside specific variants that can aid in the treatment of malignant hematopoietic diseases. His innovative approach holds promise for improving therapeutic strategies against such formidable illnesses.
Career Highlights
Throughout his career, Patrick Cormier has been associated with renowned institutions, such as the Centre National de la Recherche Scientifique and the Centre Hospitalier Universitaire de Brest. His roles in these organizations have provided him with the environment and resources necessary to refine his research and contribute meaningfully to the scientific community.
Collaborations
Cormier has collaborated with esteemed colleagues, including Bertrand Cosson and Hussam Saad. Their collective expertise and efforts strengthen the research initiatives aimed at developing effective treatments for cancer, illustrating the importance of teamwork in scientific advancements.
Conclusion
In summary, Patrick Cormier's work exemplifies the essence of innovation in the medical field. His patent on peptides for treating chronic lymphoid leukaemia underscores his dedication to developing solutions that could have a lasting impact on cancer therapy. As he continues to push the boundaries of research, Cormier remains a notable figure in the landscape of medical inventors.